Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation
Clinical trial NCT06536400 · RECRUITING
Trial details
- NCT number
- NCT06536400
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-25
- Primary completion
- 2026-08-30
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.